Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation
Journal of the American Heart Association · 17.06.2025 · 14 (12)
DOI: 10.1161/jaha.124.040360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 17.06.2025. Verfasst von Paula Tiili und 15 weiteren Autor:innen. Beteiligte Einrichtung: Primary Health Care Unit Helsinki University Hospital Helsinki Finland. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Hemorrhagic Stroke. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Despite increased atrial fibrillation (AF) and oral anticoagulation (OAC) use among patients with intracerebral hemorrhage, trends in hemorrhagic stroke (HS) incidence in AF remain unclear. We examined recent epidemiological trends, considering advances in stroke prevention and an aging population. Methods and Results A Finnish nationwide study using linked administrative registries followed 168 121 patients with incident AF (2009–2017) until the first‐ever intracerebral or subarachnoid hemorrhage, death, or study end (November 2018). HS incidence rates, the proportion of fatal cases (case fatality rate %), and anticoagulant purchases within 90 days before HS were analyzed. Temporal trends were assessed using logistic and Poisson regression. A total of 1890 patients with AF (53% women, median age 80.2) experienced their first‐ever HS. The average annual incidence rate was 2.82/1000 PY (95% CI, 2.72–2.92), remaining stable over 10 years (range 2.62–3.22). Age‐standardized incidence rates were 2.65 (2.48–2.82) for women and 2.94 (2.70–3.15) for men. The annual case fatality rate averaged 46.5% (43.9%–49.1%) without notable temporal or sex differences. Older age was associated with higher incidence rates and case fatality rate, with an increasing proportion of patients over 84. Prior OAC use increased: in 2009, 67% were not on OACs but by 2018, one third used warfarin, one third direct OACs, and only one third were without any OAC. No association was found between anticoagulation and HS case fatality.
Conclusions
Among the population with incident AF, we observed a stable first‐ever HS incidence rate and short‐term case fatality over the past decade despite a marked increase in prior oral anticoagulation use and aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Primary Health Care Unit Helsinki University Hospital Helsinki Finland.
- University of Helsinki Helsinki Finland.
- Jorvi Hospital, Department of Internal Medicine Helsinki University Hospital Espoo Finland.
- Department of Industrial Engineering and Management Aalto University Espoo Finland.
- University of Eastern Finland Kuopio Finland.
- Department of Neurosurgery Helsinki University Hospital Helsinki Finland.
ORCID-Profile: Paula Tiili, Mika Lehto, Olli Halminen, Jari Haukka, Ossi Lehtonen, Jarno Satopää, Miikka Korja, Janne Kinnunen, Aapo L Aro, Pirjo Mustonen, Juha Hartikainen, K E Juhani Airaksinen, Jukka Putaala
Zitieren
APA
Tiili, P., Lehto, M., Halminen, O., Haukka, J., Lehtonen, O., Linna, M., Satopää, J., Korja, M., Niemelä, M., Kinnunen, J., Aro, A. L., Mustonen, P., Hartikainen, J., Airaksinen, K. E. J., Putaala, J., & FinACAF study group (2025). Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation. Journal of the American Heart Association, 14(12). https://doi.org/10.1161/jaha.124.040360
Vancouver
Tiili P, Lehto M, Halminen O, Haukka J, Lehtonen O, Linna M, et al. Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation. Journal of the American Heart Association. 2025;14(12). doi:10.1161/jaha.124.040360
BibTeX
@article{Tiili2025,
author = {Tiili, Paula and Lehto, Mika and Halminen, Olli and Haukka, Jari and Lehtonen, Ossi and Linna, Miika and Satopää, Jarno and Korja, Miikka and Niemelä, Mika and Kinnunen, Janne and Aro, Aapo L and Mustonen, Pirjo and Hartikainen, Juha and Airaksinen, K E Juhani and Putaala, Jukka and FinACAF study group, FinACAF study group},
title = {Hemorrhagic Stroke in Atrial Fibrillation: Trends in Incidence, Case Fatality, and Prior Oral Anticoagulation},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {12},
doi = {10.1161/jaha.124.040360}
}
EUVIMED